azacitidine has been researched along with Frontotemporal Lobar Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banzhaf-Strathmann, J; Claus, R; Cruts, M; De Deyn, PP; Edbauer, D; Engelborghs, S; Mücke, O; Plass, C; Rentzsch, K; van Broeckhoven, C; van der Zee, J | 1 |
1 other study(ies) available for azacitidine and Frontotemporal Lobar Degeneration
Article | Year |
---|---|
Promoter DNA methylation regulates progranulin expression and is altered in FTLD.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Azacitidine; Brain; Cell Line; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Enzyme Inhibitors; Female; Frontotemporal Lobar Degeneration; Gene Expression Regulation; HEK293 Cells; Humans; Intercellular Signaling Peptides and Proteins; Male; Mice; Middle Aged; Parkinson Disease; Progranulins; Promoter Regions, Genetic; RNA, Messenger | 2013 |